Predictors of circulating endothelial progenitor cell levels in patients without known coronary artery disease referred for multidetector computed tomography coronary angiography.

[1]  Qingbo Xu,et al.  Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. , 2009, Blood.

[2]  S. Rajagopalan,et al.  Multislice Computed Tomography in the Exclusion of Coronary Artery Disease in Patients With Presurgical Valve Disease , 2009, Circulation. Cardiovascular imaging.

[3]  H. Figulla,et al.  Endothelial progenitor cells in adolescents: impact of overweight, age, smoking, sport and cytokines in younger age , 2009, Clinical Research in Cardiology.

[4]  A. M. Leone,et al.  Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial. , 2008, International journal of cardiology.

[5]  M. Pirro,et al.  Review: Hypercholesterolemia-associated endothelial progenitor cell dysfunction , 2008, Therapeutic advances in cardiovascular disease.

[6]  G. Patti,et al.  Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody‐coated stent: A prospective single‐center registry in high‐risk patients , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  A. Oliveras,et al.  Endothelial progenitor cells are reduced in refractory hypertension , 2008, Journal of Human Hypertension.

[8]  M. Flesch,et al.  Abstract 3696: Decreased Number Of Circulating Progenitor Cells In Obesity -Beneficial Effects Of Weight Reduction , 2007 .

[9]  Qingbo Xu,et al.  Endothelial Progenitor Cells, Cardiovascular Risk Factors, Cytokine Levels and Atherosclerosis – Results from a Large Population-Based Study , 2007, PloS one.

[10]  R. Blindt,et al.  Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. , 2007, Atherosclerosis.

[11]  A. Simon,et al.  Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis. , 2007, Atherosclerosis.

[12]  W. Shen,et al.  Circulating Endothelial Progenitor Cells, C-Reactive Protein and Severity of Coronary Stenosis in Chinese Patients with Coronary Artery Disease , 2007, Hypertension Research.

[13]  N. Chaturvedi,et al.  Reduced endothelial progenitor cells in European and South Asian men with atherosclerosis , 2007, European journal of clinical investigation.

[14]  D. Link,et al.  The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. , 2006, Journal of the American College of Cardiology.

[15]  J. Leor,et al.  Endothelial progenitors: a new Tower of Babel? , 2006, Journal of the American College of Cardiology.

[16]  M. Chopp,et al.  Neurorestorative treatment of stroke: Cell and pharmacological approaches , 2006, NeuroRX.

[17]  A. Avogaro,et al.  Peripheral Blood CD34+KDR+ Endothelial Progenitor Cells Are Determinants of Subclinical Atherosclerosis in a Middle-Aged General Population , 2006, Stroke.

[18]  A. Avogaro,et al.  Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[19]  A. Avogaro,et al.  Characterization of endothelial progenitor cells. , 2005, Biochemical and biophysical research communications.

[20]  B. Garmy-Susini,et al.  Circulating endothelial progenitor cells , 2005, British Journal of Cancer.

[21]  G. Nickenig,et al.  Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.

[22]  S. Fichtlscherer,et al.  Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair , 2005, Circulation.

[23]  P. Serruys,et al.  Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. , 2005, Journal of the American College of Cardiology.

[24]  H. Miller,et al.  Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. , 2004, European heart journal.

[25]  A. Quyyumi,et al.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.

[26]  G. Gurtner,et al.  Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures , 2002, Circulation.

[27]  J. Isner,et al.  HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. , 2001, The Journal of clinical investigation.

[28]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[29]  S. Fichtlscherer,et al.  Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease , 2001, Circulation.

[30]  T. Murohara,et al.  Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction , 2001, Circulation.

[31]  S. Rafii,et al.  Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+AC133+ Endothelial Precursor Cells , 2001, Circulation research.

[32]  Hiroshi Takahashi,et al.  Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon , 1999, Nature Medicine.

[33]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[34]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[35]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[36]  G. Borkan,et al.  Assessment of abdominal fat content by computed tomography. , 1982, The American journal of clinical nutrition.

[37]  R. Frye,et al.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. , 1975, Circulation.

[38]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[39]  Chi‐Hang Lee,et al.  Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up. , 2008, American heart journal.

[40]  J. Leitner,et al.  Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation. , 2008, Thrombosis research.

[41]  Frank J T Staal,et al.  Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. , 2004, Diabetes.

[42]  P. Renshaw,et al.  [Detection, evaluation, and treatment of high blood cholesterol in adults]. , 2001, Revista panamericana de salud publica = Pan American journal of public health.

[43]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary , 1998 .